Skip to main content

Fiscal Wizard · Single-issue tearsheet

LUCD / Jun 21, 2026 Run #7339

LUCD

Lucid Diagnostics Inc.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Composite verdict

F 10.3 / 100
Bearish setup · Reversal 9 drivers · 6 gates blocking
  • Williams %R
  • Engulfing
  • Double 7s
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 111th of 141 in Medical Devices

rescore-sweep
Technical synthesisRegime: range
Bull 0%Evidence: High · 23 signals100% Bear
Momentum Bearish 14Mean-reversion Bearish 37

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

20.5 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Inventory Turnover 100
Return on Capital Employed 0
Revenue Growth (YoY) 100
Return on Assets 0
Days Sales Outstanding 87
Greenblatt ROC 0

Technicals Bearish

0.1 / 100

Bearish setup leads (Williams %R, Engulfing, Double 7s); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Williams %R 9
Engulfing 11
Double 7s 15

Risk Gates

6 blocking 5 caution

6 guards active, 17 signals gated.

Altman Z-Score Blocking

Bottom-band Altman Z blocks bullish signals — distress risk.

Debt-to-Assets Blocking

High debt-to-assets blocks bullish signals — balance-sheet leverage risk.

Debt-to-Equity Blocking

High debt-to-equity blocks bullish signals — leverage risk.

Interest Coverage Blocking

Weak interest coverage blocks bullish signals — debt-service risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for LUCD.